Stocks
Immunome (IMNM) ROA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | -42.7% | -153.4% | -71.9% | -121.9% | -31.1% | -36.2% | ||
| Changes by years, y/y, % | -3pp | -111pp | +82pp | -50pp | +91pp | -4.9% | |||
Immunome. ROA, %
Immunome. ROA, changes, pp
Immunome (IMNM) ROA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROA, % | ? | -59.9% | -71.7% | -74.4% | -31.1% | -36.2% | -36.2% | |
| Changes by years, y/y, % | +13pp | +17pp | +44pp | +91pp | +24pp | |||
| Changes by quarters, q/q, % | +62pp | -12pp | -3pp | +43pp | -5pp | |||
